8-K current report · filed Sep 11, 2026

Teva Pharmaceutical Industries Ltd (TEVA) 8-K Current Report: September 11, 2026

Item 7.01Item 8.01Item EX-99.1TEVA overview

Short answer

Teva Pharmaceutical Industries Ltd (TEVA) filed an 8-K current report with the SEC on September 11, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Teva announced pricing of securities on September 10, 2026.

Teva Pharmaceutical Industries Ltd 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Teva announced pricing of securities on September 10, 2026
  • Exhibit 99.1 contains the pricing press release and is the key source for deal terms
  • Securities pricing may affect Teva’s capital structure and future financing obligations

Item 8.01 · Other Events

  • Planned issuance: €1.5B and $3.2B senior notes, totaling five tranches with maturities from 2032 to 2037
  • Coupon rates: 4.250% to 4.625% on Euro Notes and 5.250% to 5.750% on USD Notes
  • Proceeds increase Teva’s debt burden, while staggered maturities support long-term refinancing and liquidity management
  • Notes priced below par at 98.327% to 98.993%, implying issuance proceeds below aggregate principal amounts
  • Closing expected September 16, 2026, with Teva providing guarantees for issuer subsidiaries

Item EX-99.1 · Exhibit EX-99.1

  • $4.9B senior-notes offering priced across EUR and USD tranches, increasing near-term refinancing capacity
  • Coupon rates 4.250% to 5.750%, with maturities spanning 2032 to 2037
  • Proceeds target redemption of higher-cost notes, including 6.750%, 7.875%, 7.375% and 8.125% securities
  • Planned redemptions include up to $450M due 2027 and up to €1.15B due 2030
  • Settlement expected September 16, 2026, subject to customary closing conditions

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Teva Pharmaceutical Industries Ltd 8-K filings

Get the next TEVA 8-K as it lands

Follow TEVA for push alerts, or ask the research agent what this filing means.